First, breast (MCF-7 and MDA-MB-231) and pancreatic (CAPAN-1 and PANC-1) cancer cell lines were treated using a class I pan-PI3K inhibitor (GDC-0941 [10 μM]) or vehicle (Fig 1A). Here, PIK3CA is linked to cancer.